SEC Tracker
Get the app
VJET · XBRL financial data

Catheter Precision financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal years (VJET's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue4,405—14442——
Revenue from contracts with customers4,4052214442420819
Cost of revenue5,482—16130——
Cost of goods and services sold5,4821,560161304263
Gross profit(1,077)(1,538)(147)412378756
Research and development9,00812,2536,392475272—
Selling, general and administrative25,97415,47516,25017,12211,34912,075
Total operating expenses34,98227,72826,81478,53111,62121,899
Operating income (loss)(36,059)(29,266)(26,961)(78,119)(11,243)(21,143)
Interest income129——3478134
Interest expense108—————
Other income (expense)88(14)99(8)(10)(2)
Income tax expense (benefit)74303,141(1,810)
Net income (loss)(36,045)(25,070)(26,865)(70,572)(16,643)(17,183)
Earnings per share, basic USD per share—(248.22)(25.98)(129.88)(6.68)(15.90)
Earnings per share, diluted USD per share—(248.22)(25.98)———
Weighted average shares, basic thousands of shares—1011,0345503,2641,081
Weighted average shares, diluted thousands of shares—1011,034———

Balance sheet

CSV

Fiscal years (VJET's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Cash and cash equivalents23,90615,04515,8593,5652,87388
Marketable securities—————0
Accounts receivable23821013770155
Inventory2,2189860443386
Prepaid and other current assets1,2581,03797741531661
Total current assets27,62017,08916,8364,1613,292390
Property and equipment, net3,2111,8090709164
Right-of-use asset2,4842,1100179105162
Goodwill——00—0
Total assets33,43821,04416,83630,73627,77015,860
Accounts payable571988924642301,492
Accrued liabilities4,3484,1197,4841,7331,5481,697
Total current liabilities7,7625,3907,5762,4722,0853,907
Lease liability, non-current2,2641,98109713101
Total liabilities12,2917,3717,5769,54316,0139,209
Accumulated deficit(153,202)(178,272)(205,137)(275,709)(292,352)(309,535)
Total stockholders' equity21,14713,6739,26021,19311,7577,054
Total liabilities and equity33,43821,04416,83630,73627,77015,860
Common shares outstanding (cover page) thousands of shares3,25931,4594,9847,5739,2692,692

Cash flows

CSV

Fiscal years (VJET's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Net income (loss)(36,045)(25,070)(26,865)(70,572)(16,643)(17,183)
Stock-based compensation4,0822,2374471,21754338
Depreciation and amortization———2,0752,1092,115
Net cash from operating activities(28,304)(27,625)(22,568)(20,619)(9,271)(8,296)
Purchases of property and equipment6726517766717
Net cash from investing activities15,9333,80221(61)(67)167
Proceeds from issuing common stock—16,00018,906238——
Net cash from financing activities21,69314,96223,3618,3868,6465,344
Net change in cash9,322(8,861)814(12,294)(692)(2,785)

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Catheter Precision6431,019(2,861)*14.4M0.6 quarters 10-QJun 30, 2026
Anteris Technologies Global249,9041,009(20,797)*97.5M12.0 quarters 10-QJun 30, 2026
STRATA Skin Sciences7,9129,292*(239)*5.9M33.1 quarters 10-KDec 31, 2025
Nuwellis3,9221,969(3,175)*3.6M1.2 quarters 10-QJun 30, 2026
Nu-Med Plus5.401.1*83.5M— 10-QJun 30, 2026
Glucotrack1,124not reported(3,616)*10.6M0.3 quarters 10-QJun 30, 2026
ENDRA Life Sciences1,740not reported(928)*1.5M1.9 quarters 10-QJun 30, 2026
Aethlon Medical4,934not reported(1,897)711,1362.6 quarters 10-QJun 30, 2026
Global Innovative Platforms24451(134)*49.8M1.8 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.